Peter Olinga

8.4k citations

175 papers · 5.4k indexed · h-index 41

Impact in

Hepatology top 0.5%
- Liver physiology and pathology
- Liver Disease and Transplantation
Pharmacology top 0.2%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection

Papers in ⓘ

Hepatology 65
- Liver physiology and pathology 53
- Liver Disease and Transplantation 15
Pharmacology 26
- Drug-Induced Hepatotoxicity and Protection 15
- Pharmacogenetics and Drug Metabolism 12

Co-authors: Geny M. M. Groothuis (49 shared papers)Dirk K. F. Meijer (26 shared papers)Marjolijn T. Merema (19 shared papers)Henricus A. M. Mutsaers (22 shared papers)Maarten J. H. Slooff (15 shared papers)Klaas Poelstra (16 shared papers)Dorenda Oosterhuis (28 shared papers)Marina H. de Jager (8 shared papers)
Journals: Toxicology in Vitro (12 papers)Journal of Hepatology (7 papers)Frontiers in Medicine (6 papers)Hepatology (5 papers)Archives of Toxicology (5 papers)
Partner nations: Netherlands United States Denmark

In The Last Decade

Peter Olinga

169 papers receiving 5.3k citations

Peers

Countries citing papers authored by Peter Olinga

Since Specialization

Citations

This map shows the geographic impact of Peter Olinga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Olinga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Olinga more than expected).

Fields of papers citing papers by Peter Olinga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Olinga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Olinga. The network helps show where Peter Olinga may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Olinga, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Olinga Line = papers co-authored together Peter Olinga links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 175 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Preparation and incubation of precision-cut liver and intestinal slices for application in drug metabolism and toxicity studies Nature Protocols ·Inge A.M. de Graaf, Peter Olinga, Marina H. de Jager, Marjolijn T. Merema, Ruben de Kanter, Esther G. van de Kerkhof, Geny M. M. Groothuis	2010	299
2	Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro Critical Care Medicine ·Maarten W. Nijsten, Peter Olinga, Hauw The, Elisabeth G.E. de Vries, Heimen Schraffordt Koops, Geny M. M. Groothuis, Pieter C. Limburg, H. J. ten Duis, Han Moshage, Harald Hoekstra, Johan Bijzet, Jan H. Zwaveling	2000	234
3	Targeting Oxidative Stress for the Treatment of Liver Fibrosis Reviews of physiology, biochemistry and pharmacology ·Theerut Luangmonkong, Su Suriguga, Henricus A. M. Mutsaers, Geny M. M. Groothuis, Peter Olinga, Miriam Boersema	2018	219
4	LPS-induced downregulation of MRP2 and BSEP in human liver is due to a posttranscriptional process American Journal of Physiology-Gastrointestinal and Liver Physiology ·Marieke G. L. Elferink, Peter Olinga, Annelies L. Draaisma, Marjolijn T. Merema, Klaas Nico Faber, Maarten J. H. Slooff, Dirk K. F. Meijer, Geny M. M. Groothuis	2004	130
5	Albumin Modified With Mannose 6–Phosphate: A Potential Carrier for Selective Delivery of Antifibrotic Drugs to Rat and Human Hepatic Stellate Cells Hepatology ·Leonie Beljaars, Grietje Molema, Betty Weert, Harmke Bonnema, Peter Olinga, Geny M. M. Groothuis, Dirk K. F. Meijer, Klaas Poelstra	1999	120
6	Precision-cut tissue slices as a tool to predict metabolism of novel drugs Expert Opinion on Drug Metabolism & Toxicology ·Inge AM de Graaf, Geny M. M. Groothuis, Peter Olinga	2007	114
7	Targeting dexamethasone to Kupffer cells: Effects on liver inflammation and fibrosis in rats Hepatology ·Barbro N. Melgert, Peter Olinga, J.J. Laan, Betty Weert, Jaejin Cho, Detlef Schuppan, Geny M. M. Groothuis, Dirk K. F. Meijer, Klaas Poelstra	2001	98
8	Comparison of five incubation systems for rat liver slices using functional and viability parameters Journal of Pharmacological and Toxicological Methods ·Peter Olinga, Kees Groen, Ingrid H. Hof, Ruben de Kanter, Henk Koster, Winfried R. Leeman, A.A.J.J.L. Rutten, Klaas van Twillert, Geny M. M. Groothuis	1997	97
9	Precision-cut liver slices: A tool to model the liver ex vivo Journal of Hepatology ·Peter Olinga, Detlef Schuppan	2013	90
10	Mucus Microbiome of Anastomotic Tissue During Surgery Has Predictive Value for Colorectal Anastomotic Leakage Annals of Surgery ·Jasper B. van Praagh, Marcus C. de Goffau, Ilsalien S. Bakker, Harry van Goor, Hermie J. M. Harmsen, Peter Olinga, Klaas Havenga	2018	88
11	Rat liver slices as a tool to study LPS-induced inflammatory response in the liver Journal of Hepatology ·Peter Olinga, Marjolijn T. Merema, Marina H. de Jager, Frans Derks, Barbro N. Melgert, Han Moshage, Maarten J. H. Slooff, Dirk K. F. Meijer, Klaas Poelstra, Geny M. M. Groothuis	2001	82
12	Precision-Cut Liver Slices as a New Model to Study Toxicity-Induced Hepatic Stellate Cell Activation in a Physiologic Milieu Toxicological Sciences ·M. van de Bovenkamp, Geny M. M. Groothuis, Annelies L. Draaisma, Marjolijn T. Merema, Judith I. Bezuijen, Marit J. van Gils, Dirk K. F. Meijer, Scott L. Friedman, Peter Olinga	2005	80
13	Liver fibrosis in vitro: Cell culture models and precision-cut liver slices Toxicology in Vitro ·M. van de Bovenkamp, Geny M. M. Groothuis, Dirk K. F. Meijer, Peter Olinga	2007	80
14	Liver slices in in vitro pharmacotoxicology with special reference to the use of human liver tissue Toxicology in Vitro ·Peter Olinga, Dirk K. F. Meijer, Maarten J. H. Slooff, Geny M. M. Groothuis	1997	80
15	Vanin 1: Its Physiological Function and Role in Diseases International Journal of Molecular Sciences ·Roberta Bartucci, Anna Salvati, Peter Olinga, Ykelien L. Boersma	2019	79
16	Drug-metabolizing activity of human and rat liver, lung, kidney and intestine slices Xenobiotica ·Ruben de Kanter, Marina H. de Jager, Annelies L. Draaisma, J. U. Jurva, Peter Olinga, Dirk Meijer, Geny M. M. Groothuis	2002	73
17	Evaluating the antifibrotic potency of galunisertib in a human ex vivo model of liver fibrosis British Journal of Pharmacology ·Theerut Luangmonkong, Su Suriguga, Emilia Bigaeva, Miriam Boersema, Dorenda Oosterhuis, Koert P. de Jong, Detlef Schuppan, Henricus A. M. Mutsaers, Peter Olinga	2017	72
18	Novel biotransformation and physiological properties of norursodeoxycholic acid in humans†‡ Hepatology ·Alan F. Hofmann, Salam Zakko, Marco Lira, Carlo Clerici, Lee R. Hagey, K. Karel Lambert, Joseph H. Steinbach, Claudio D. Schteingart, Peter Olinga, Geny M. M. Groothuis	2005	71
19	Fragments of Citrullinated and MMP-degraded Vimentin and MMP-degraded Type III Collagen Are Novel Serological Biomarkers to Differentiate Crohn’s Disease from Ulcerative Colitis Journal of Crohn s and Colitis ·Joachim Høg Mortensen, Line E. Godskesen, Michael Dam Jensen, Wouter T. van Haaften, Lone Klinge, Peter Olinga, Gerard Dijkstra, Jens Kjeldsen, M.A. Karsdal, Anne‐Christine Bay‐Jensen, Aleksander Krag	2015	70
20	Microarray analysis in rat liver slices correctly predicts in vivo hepatotoxicity Toxicology and Applied Pharmacology ·Marieke L.G. Elferink, Peter Olinga, Annelies L. Draaisma, Marjolijn T. Merema, Susanne Bauerschmidt, Jan Polman, W.G.E.J. Schoonen, Geny M. M. Groothuis	2008	70

About Peter Olinga

Peter Olinga is a scholar working on Hepatology, Pharmacology, Transplantation, Nephrology and Epidemiology, having authored 175 papers that have together received 5.4k indexed citations. Recurring topics across this work include Liver physiology and pathology (53 papers), Liver Disease Diagnosis and Treatment (41 papers), Organ Transplantation Techniques and Outcomes (24 papers), Drug Transport and Resistance Mechanisms (21 papers), Drug-Induced Hepatotoxicity and Protection (15 papers), Liver Disease and Transplantation (15 papers), Pharmacogenetics and Drug Metabolism (12 papers) and Chronic Kidney Disease and Diabetes (11 papers). The work is most often cited by research in Hepatology (1.7k citations), Pharmacology (828 citations), Epidemiology (1.5k citations), Transplantation (111 citations) and Oncology (1.0k citations). Peter Olinga has collaborated with scholars based in Netherlands, United States and Denmark. Frequent co-authors include Geny M. M. Groothuis, Dirk K. F. Meijer, Marjolijn T. Merema, Henricus A. M. Mutsaers, Maarten J. H. Slooff, Klaas Poelstra, Dorenda Oosterhuis, Marina H. de Jager, Theerut Luangmonkong and Ruben de Kanter. Their work appears in journals such as Toxicology in Vitro, Journal of Hepatology, Frontiers in Medicine, Hepatology and Archives of Toxicology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact